SCHEMBL1895083

SCHEMBL1895083

Cc1ccc(C=C(C(=O)OC(C)(C)C)C(=O)c2ccccc2O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.47
MEN1 O00255 6/20 0.41
KMT2A Q03164 6/20 0.41
LMNA P02545 6/20 0.40
TP53 P04637 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HSD17B10 Q99714 2/20 0.40
NPC1 O15118 1/20 0.40
NFKB1 P19838 1/20 0.40
HTT P42858 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
PNLIP P16233 1/20 0.38
POLB P06746 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
MAPK1 P28482 2/20 0.36
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1895080 1.00 MAPT (0.47) MAPTMEN1KMT2ALMNATP53
SCHEMBL1895082 1.00 MAPT (0.47) MAPTMEN1KMT2ALMNATP53
SCHEMBL1887493 0.91 MEN1 (0.48) MAPTMEN1KMT2ALMNARAB9A
SCHEMBL1887496 0.91 MEN1 (0.48) MAPTMEN1KMT2ALMNARAB9A
SCHEMBL1887498 0.91 MEN1 (0.48) MAPTMEN1KMT2ALMNARAB9A
SCHEMBL1895191 0.89 MAPT (0.47) MAPTMEN1KMT2ALMNARAB9A
SCHEMBL1895189 0.89 MAPT (0.47) MAPTMEN1KMT2ALMNARAB9A
SCHEMBL1890302 0.88 MAOB (0.51) MAPTMEN1KMT2ALMNARAB9A
SCHEMBL1890304 0.88 MAOB (0.51) MAPTMEN1KMT2ALMNARAB9A
SCHEMBL1890301 0.88 MAOB (0.51) MAPTMEN1KMT2ALMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110117649-A1 Catalytic enantioselective synthesis of flavanones and chromanones NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2011-05-19 US disclosed
US-7851640-B2 Catalytic enantioselective synthesis of flavanones and chromanones NORTHWESTERN UNIVERSITY (US) 2010-12-14 US disclosed
US-20090259055-A1 Catalytic enantioselective synthesis of flavanones and chromanones NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-10-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090259055-A1 Catalytic enantioselective synthesis of flavanones and chromanones RNGTT, CDK20, TBXAS1 MAPT 4627/4885MEN1 4332/4885KMT2A 2596/4885
US-20110117649-A1 Catalytic enantioselective synthesis of flavanones and chromanones RNGTT, CDK20, TBXAS1 MAPT 4627/4885MEN1 4332/4885KMT2A 2596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.